| Type of Sickle | Total | |||||
Hb SB + thalassemia | Hb SB 0-thalassemia | Hb SC | Hb SS | SCT | |||
Venous phase | Well defined enhanced lesion | - | - | 1 (3.1%) | 2 (6.3%) | 1 (3.1%) | 4 (12.5%) |
Well defined non enhanced lesion (hypo dense) | - | 2 (6.3%) | 3 (9.4%) | 10 (31.3%) | 0 (0.0%) | 15 (46.9%) | |
Multiple well defined non enhance lesions | - | - | - | 2 (6.3%) | - | 2 (6.3%) | |
Peripheral hypo dense enhanced lesion | - | - | - | 1 (3.1%) | - | 1 (3.1%) | |
Hypo dense lesion surround by enhancing calcification | - | 1 (3.1%) | - | - | - | 1 (3.1%) | |
Homogenous hypo dense with well defined peripheral enhancement | - | - | - | 2 (6.3%) | - | 2 (6.3%) | |
Heterogeneous pattern | - | - | 1 (3.1%) | - | - | 1 (3.1%) | |
Ill defined non enhanced lesion (hypo dense) | 2 (6.3%) | 2 (6.3%) | 1 (3.1%) | 1 (3.1%) | - | 6 (18.8%) | |
Total | 2 (6.3%) | 5 (15.6%) | 6 (18.8%) | 18 (56.3%) | 1 (3.1%) | 32 (100.0%) | |
P-value = 0.037 |